ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Neurology

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

6,944Medicare Part D Prescriptions Filled, Including Refills

Rank: 11 out of 520

$846K Total Retail Price of All Prescriptions

Rank: 51 out of 520

626 Patients Receiving at Least One Drug in Part D
33%Patients 65 Years and Older
75% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

28% of this provider’s 626 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

30% of this provider’s 626 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

3% of this provider’s 2,001 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$122 was the average price of a prescription from this provider, compared to $204 among peers.

Prescriptions per Patient

11 is the average number of prescriptions (including refills) per patient, compared to an average of 8.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
HYDROCODONE-ACETAMINOPHEN 818 275 S3 1 7
GABAPENTIN 424 130 2 1
LYRICA 322 126 3 11
TIZANIDINE HCL 314 67 4 25
METHADONE HCL 312 73 S2 5 48
CARISOPRODOL 245 21 R 6 37
FENTANYL 196 61 S2 7 52
OXYCODONE HCL-ACETAMINOPHEN 194 85 S2 8 30
TOPIRAMATE 188 39 9 6
MELOXICAM 172 71 10 33
MORPHINE SULFATE ER 165 22 S2 11 31
CARBAMAZEPINE 153 37 12 20
LEVETIRACETAM 143 17 13 5
OXYCODONE HCL 140 36 S2 14 19
PHENYTOIN SODIUM EXTENDED 139 43 15 24
METHOCARBAMOL 136 32 R 16 66
TRAMADOL HCL 127 34 17 26
ZOLPIDEM TARTRATE 125 57 18 22
DONEPEZIL HCL 122 94 19 3
HYDROMORPHONE HCL 111 0 S2 20 67
AMITRIPTYLINE HCL 91 17 R 21 16
DIVALPROEX SODIUM ER 88 0 22 45
CYMBALTA 83 25 23 14
ZONISAMIDE 80 12 24 36
NAMENDA 79 75 25 4
CYCLOBENZAPRINE HCL 79 0 R 25 34
PRIMIDONE 66 34 27 8
VIMPAT 66 0 27 41
NORTRIPTYLINE HCL 64 0 29 32
ROPINIROLE HCL 62 31 30 12
MORPHINE SULFATE 61 0 S2 31 70
BACLOFEN 59 0 32 18
TRAZODONE HCL 54 30 33 28
IBUPROFEN 51 0 34 65
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 18, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.